SUMMARY: The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive…
An Exciting Strategic Collaboration between Dunad Therapeutics and Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies.
KEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies,…
Australian Regulatory Agency, TGA Unveil New Classification of Active Medical Devices Inclusion to Software Based Medical Devices for Industry Guidance.
This information is provided to assist you if you are new to engaging with the…